JUAN
SANCHIS FORES
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublications in collaboration with researchers from Hospital Universitario Marqués de Valdecilla (21)
2024
-
Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes
European Journal of Internal Medicine, Vol. 127, pp. 126-133
2023
-
Changes in the Treatment Strategy Following Intracoronary Pressure Wire in a Contemporaneous Real-Life Cohort of Patients With Intermediate Coronary Stenosis. Results From a Nationwide Registry
Cardiovascular Revascularization Medicine, Vol. 51, pp. 55-64
-
Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry
Minerva cardiology and angiology, Vol. 71, Núm. 3, pp. 284-293
2022
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
-
Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study
Journal of Geriatric Cardiology, Vol. 19, Núm. 5, pp. 354-366
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
2021
-
Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis
Cardiovascular Revascularization Medicine, Vol. 31, pp. 1-6
-
Temporal trends in postinfarction ventricular septal rupture: the CIVIAM Registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 757-764
2020
-
Efectos de la pandemia de COVID-19 sobre la población mayor de 75 años con revascularización coronaria previa: Subanálisis del registro EPIC SIERRA 75
REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 321-322
2019
-
Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1005-1011
-
Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry
Revista Espanola de Cardiologia, Vol. 72, Núm. 5, pp. 373-382
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
-
Multivessel disease in patients over 75 years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI + 75 nation-wide registry
Cardiovascular Revascularization Medicine, Vol. 19, Núm. 5, pp. 580-588
2017
-
Angioplastia primaria en mayores de 75 años. Perfil de pacientes y procedimientos, resultados y predictores pronósticos en el registro ESTROFA IM + 75
Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 81-87
-
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990
2016
-
Everolimus-eluting stents in patients with bare-metal and drug-eluting in-stent restenosis
Circulation: Cardiovascular Interventions, Vol. 9, Núm. 7
-
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial
JACC: Cardiovascular Interventions, Vol. 9, Núm. 12, pp. 1246-1255
2015
-
Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2
Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 838-845
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386
2010
-
Thrombosis of second-generation drug-eluting stents in real practice: Results from the multicenter Spanish registry ESTROFA-2 (estudio espaol sobre trombosis de stents farmacoactivos de segunda generacion-2)
JACC: Cardiovascular Interventions, Vol. 3, Núm. 9, pp. 911-919